Linomide induces apoptotic death of cortical CD4/CD8 double positive thymocytes and thymic atrophy by a corticosteroid-lndependent pathway

Clinical Immunology

Volumn 90, Issue 1, 1999, Pages 108-114

  Arbel, I ^a   Chezen, E ^a   Abramsky, O ^a   Karpati, T ^a   Ovadia, H ^a   Mizrachi Koll, R ^a   Karussis, D ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Apoptosis; Autoimmunity; CD8 cells; Linomide; Thymus

Indexed keywords

CORTICOSTEROID; ROQUINIMEX;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; HELPER CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; THYMECTOMY; THYMOCYTE; THYMUS ATROPHY;

EID: 0032929246     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1998.4613     Document Type: Article

References (48)

1. Kalland T., Alm G., Stalhandske T. Augmentation of mouse natural killer activity by LS-2616, a new immunomodulator. J. Immunol. 134:1985;3956.
2. Kalland T. Regulation of natural killer progenitors. Studies with a novel immunomodulator with distinct effects at the precursor level. J. Immunol. 144:1990;4472-4476.
3. Bengtsson M., Simonsson B., Carlsson K. Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator Linomide after autologous bone marrow transplantation. A pilot study in patients with acute myeloid leukemia. Transplantation. 53:1992;882-888.
4. Gonzalo J. A., Gonzalez-Garcia A., Kalland T., Hedlund G., Martinez C., Kroemer G. Linomide, a novel immunomodulator that prevents death in four models of septic shock. Eur. J. Immunol. 23:1993;2372-2374.
5. Gonzalo J. A., Gonzalez-Garcia A., Kalland T., Hedlund G., Martinez C., Kroemer G. Linomide inhibits programmed cell death of peripheral T cellsin vivo. Eur. J. Immunol. 24:1994;48-52.
6. Ichikawa T., Lamb J. C., Christensson P. I., Hartley-Asp B., Isaacs J. T. The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers. Cancer Res. 52:1992;3022-3028.
7. Ilback N. G., Fohlan J., Slorach S., Friman G. Effects of the immunomodulator LS 2616 on lymphocyte subpopulations in murine Coxsackie virus B3 myocarditis. J. Immunol. 142:1989;3225-3228.
8. Larsson E. L., Joki A., Stalhandske T. Mechanism of action of the new immunomodulator LS-2616 on T-cell responses. Int. J. Immunopharmacol. 9:1987;425.
9. Vukanovic J., Passaniti A., Hirata T., Traystman R. J., Hartley-Asp B., Isaacs J. T. Antiangiogenic effects of the quinoline-3-carboxamide linomide. Cancer Res. 53:1993;1833-1837.
10. Harning R., Koo G. C., Szalay J. Immune regulation of metastasis fromin vivo. Reg. Immunol. 3:1990;97-102.
11. Harning R., Koo G. C., Szalay J. Regulation of the metastasis of murine ocular melanoma by natural killer cells. Invest. Ophthalmol. Vis. Sci. 30:1989;1909-1915.
12. Weidenfeld J., Karussis D., Abramsky O., Lehmann D., Arbell I., Ovadia H. Linomide activates the adrenocortical axis in the rat: Inhibition of experimental autoimmune encephalomyelitis by linomide is not related to the increase of corticosterone. J. Neuroimmunol. 79:1997;49-53.
13. Stalhandske T., Eriksson E., Sandberg B. M. A novel quinoline-carboxamide with interesting immunomodulating activity. Int. J. Immunopharmacol. 4:1982;336.
14. Lehmann D., Karussis D. M., Fluresco D. Immunomodulation of autoimmunity by Linomide: Inhibition of antigen presentation through down regulation of macrophage activity in a model of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 74:1997;102-110.
15. Harning R., Szalay J. A treatment for metastasis of murine ocular melanoma. Invest. Ophthalm. Vis. Sci. 29:1988;1505-1510.
16. Bjork J., Kleinau S. Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice. Agents Actions. 27:1989;319-321.
17. Kleinau S., Larsson P., Bjork J., Holmdahl R., Klareskog L. Linomide, a new immunomodulatory drug, shows different effects on homologous versus heterologous collagen induced arthritis in rats. Clin. Exp. Immunol. 78:1989;138-142.
18. Slavin S., Sidi H., Weiss L., Rosenman E., Kalland T., Gross D. Linomide, a new treatment for autoimmune diseases: The potential in type 1 diabetes. Diabetes Metab. Rev. 9:1993;311-315.
19. Spetz-Hagberg A. L., Goldschmidt T. J., Stalhandske T., Larsson-Sciard E. L. Amelioration of intrathymic T cell development and peripheral T cell reactivities in autoimmune mice undergoing therapy with a novel immunomodulator. Int. Immunol. 2:1990;645-650.
20. Tarkowski A., Gunnarsson K., Nilsson L. A., Lindholm L., Stalhandske T. Successful treatment of autoimmunity in MRL/J mice with LS-2616, a new immunomodulator. Arthritis Rheum. 29:1986;1405.
21. Tarkowski A., Gurnarsson K., Stalhandske T. Effects of LS-2616 administration upon the autoimmune disease of (NZBXNZW)F1 hybrid mice. Immunology. 59:1986;589.
22. Karussis D. M., Lehmann D., Brenner T. Immunomodulation of experimental autoimmune myasthenia gravis with linomide. J. Neuroimmunol. 55:1994;187-193.
23. Karussis D. M., Slavin S., Lehmann D. Successful treatment of chronic-relapsing experimental autoimmune encephalomyelitis with linomide (LS-2616), a synthetic immunomodulator. Proc. Natl. Acad. Sci. USA. 90:1993;6400-6404.
24. Karussis D. M., Lehmann D., Slavin S. Inhibition of acute experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide. Ann. Neurol. 34:1993;654-660.
25. Karussis D. M., Lehmann D., Slavin S. Immunomodulation of autoimmunity by Linomide. Isr. J. Med. Sci. 31:1995;38-41.
26. Owen J. J., Jenkinson E. J. Apoptosis and T-cell repertoire selection in the thymus. Ann. N. Y. Acad. Sci. 663:1992;305-310.
27. Shortman K., Scollay R. Immunology. Death in the thymus [news; comment]. Nature. 372:1994;44-45.
28. Surh C. D., Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus [see comments]. Nature. 372:1994;100-103.
29. Masaoka A., Yamakawa Y., Niwa H. Extended thymectomy for myasthenia gravis patients: A 20-year review. Ann. Thoracic Surg. 62:1996;853-859.
30. Deckers C. L., Lyons A. B., Samuel K., Sanderson A., Maddy A. H. Alternative pathways of apoptosis induced by methylprednisolone and valinomycin analyzed by flow cytometry. Exp. Cell Res. 208:1993;362-370.
31. Gruber J., Sgonc R., Hu Y. H., Beug H., Wick G. Thymocyte apoptosis induced by elevated endogenous corticosterone levels. Eur. J. Immunol. 24:1994;1115-1121.
32. Ishii T., Nakamura M., Yagi H. Glucocorticoid-induced thymocyte death in the murine thymus: The effect at later stages. Arch. Histol. Cytol. 60:1997;65-78.
33. Silverstone A. E., Frazier D. E. Jr., Fiore N. C., Soults J. A., Gasiewicz T. A. Dexamethasone, beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 126:1994;248-259.
34. Vacchio M. S., Ashwell J. D. Thymus-derived glucocorticoids regulate antigen-specific positive selection. J. Exp. Med. 185:1997;2033-2038.
35. Gavrieli Y., Sherman Y., Ben Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
36. Douek D. C., Corley K. T., Zal T., Mellor A., Dyson P. J., Altmann D. M. Negative selection by endogenous antigen and superantigen occurs at multiple thymic sites. Int. Immunol. 8:1996;1413-1420.
37. Zheng B., Han S., Zhu Q., Goldsby R., Kelsoe G. Alternative pathways for the selection of antigen-specific peripheral T cells. Nature. 384:1996;263-266.
38. Clayton L. K., Ghendler Y., Mizoguchi E. T-cell receptor ligation by peptide/MHC induces activation of a caspase in immature thymocytes: The molecular basis of negative selection. EMBO J. 16:1997;2282-2293.
39. Cairns J. S., Mainwaring M. S., Cacchione R. N., Walker J. A., McCarthy S. A. Regulation of apoptosis in thymocytes. Thymus. 21:1993;177-193.
40. ++. Science. 250:1990;1720-1723.
41. Castro J. E., Listman J. A., Jacobson B. A. Fas modulation of apoptosis during negative selection of thymocytes. Immunity. 5:1996;617-627.
42. ++. Proc. Natl. Acad. Sci. USA. 90:1993;10340-10344.
43. ++. J. Exp. Med. 181:1995;485-491.
44. Cohen P. L., Eisenberg R. A. The lpr and gld genes in systemic autoimmunity: Life and death in the Fas lane [published erratum appears inImmunol. Today14. Immunol. Today. 13:1992;427-428.
45. Ferguson T. B., Clifford D. B., Montgomery E. B., Bruns K. A., McGregor P. J., Trotter J. L. Thymectomy in multiple sclerosis. Two preliminary trials. J. Thoracic Cardiovasc. Surg. 85:1983;88-93.
46. McCarthy S. A., Cacchione R. N., Mainwaring M. S., Cairns J. S. The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. Transplantation. 54:1992;543-547.
47. Saiagh S., Fabien N., Auger C., Monier J. C. Induction of apoptosis in mouse thymocytes by cyclosporin A: In vivo study. Immunopharmacol. Immunotoxicol. 16:1994;359-388.
48. Redondo C., Flores I., Gonzalez A. Linomide prevents the lethal effect of anti-Fas antibody and reduces Fas-mediated ceramide production in mouse hepatocytes. J. Clin. Invest. 98:1996;1245-1252.